Infections caused by Mycobacterium abscessus appear to be increasing in frequency among the immunocompromised population and are challenging to treat. Antibiotic options in these cases are scarce, prolonged therapy is required and new options are needed. We will discuss this important topic with experts in the field.
- Define M. abscessus as an opportunistic pathoge
- The intrinsic phenotypic characteristics of M. abscessus, including resistance to common antimicrobials
- Treatment approaches and rationale for these strategies
- Kelly Dooley, MD. PhD, MPH., Professor and Addison B. Scoville Jr. Chair in Medicine, and Director of the Division of Infectious an infectious within the Department of Medicine at Vanderbilt University Medical Center (VUMC)
- Charles L. Daley, MD, Professor and Chief of the Division of Mycobacterial and Respiratory Infections. National Jewish Health
- Thomas Dick, PhD. Professor, Center for Discovery and Innovation, Hackensack Meridian Health
This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.